We are live on
!
Find out more
CIC
Carnegie Investment Counsel Portfolio holdings
AUM
$4.99B
1-Year Est. Return
23.08%
This Fund
S&P 500
This Quarter
Est. Return
+4.43%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$440M
AUM Growth
+$60.4M
(+16%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
9.88%
Top 10 Holdings %
Top 10 Hldgs %
17.71%
Holding
235
New
23
Increased
120
Reduced
64
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$7.63M |
| 2 |
ANSS
Ansys
ANSS
|
+$3.61M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.79M |
| 4 |
Neogen
NEOG
|
+$1.75M |
| 5 |
Amgen
AMGN
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NE
Noble Corporation
NE
|
+$806K |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$392K |
| 3 |
Walmart Inc
WMT
|
+$350K |
| 4 |
Apple
AAPL
|
+$318K |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$309K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 13.15% |
| 2 | Technology | 12.47% |
| 3 | Energy | 11.87% |
| 4 | Healthcare | 10.84% |
| 5 | Consumer Staples | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Zimmer Biomet
ZBH
$18.6B
| $204K | 0.05% |
+2,023
| New | +$197K |
|
227
iShares MSCI Malaysia ETF
EWM
$331M
| $187K | 0.04% |
2,946
-125
| -4% | -$7.97K |
|
|
RIT
228
DELISTED
LMP REAL ESTATE INCOME FUND INC. COM
RIT
| $128K | 0.03% |
11,140
-850
| -7% | -$9.62K |
|
229
iShares Core S&P Total US Stock Market ETF
ITOT
$98B
| – | – |
-4,990
| Closed | -$214K |
|
230
Teva Pharmaceuticals
TEVA
$42.9B
| – | – |
-3,800
| Closed | -$201K |
|
231
Texas Instruments
TXN
$261B
| – | – |
-5,950
| Closed | -$281K |
|
232
Vanguard Morningstar Large-Cap ETF
VV
$54.6B
| – | – |
-3,580
| Closed | -$308K |
|
|
233
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| – | – |
-8,259
| Closed | -$392K |
|
|
NE
234
DELISTED
Noble Corporation
NE
| – | – |
-28,150
| Closed | -$806K |
|
|
HBANP
235
DELISTED
Huntington Bancshars Inc. Pfd Ser A
HBANP
| – | – |
-200
| Closed | -$260K |
|
Similar funds
MA
SNT
AM
SGM
PAMP
BCM
NL
O
Carnegie Investment Counsel's Q2 2014 Portfolio in Review
As of Q2 2014, Carnegie Investment Counsel held 235 positions worth $440M, up 16% from $379M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Carnegie Investment Counsel deployed $43.5M of net new capital in Q2 2014, opening 23 new positions and adding to 120 existing holdings. Its largest new stake was Ansys: 48,095 shares worth $3.65M.
By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 11% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Walmart Inc, an estimated $350K trimmed.
- Carnegie Investment Counsel's largest Q2 2014 buy was Ansys: 48,095 shares worth $3.65M.
- Carnegie Investment Counsel added most to Northrop Grumman in Q2 2014, an estimated $7.63M increase.
- Carnegie Investment Counsel's biggest Q2 2014 reduction was Walmart Inc, cutting an estimated $350K.
- Carnegie Investment Counsel fully exited Noble Corporation in Q2 2014, selling an estimated $806K.
- Carnegie Investment Counsel's ten largest holdings make up 18% of its $440M portfolio in Q2 2014.
- Carnegie Investment Counsel opened 23 new positions and closed 7 in Q2 2014.
- Carnegie Investment Counsel's portfolio value rose 16% quarter-over-quarter to $440M.
Based on Carnegie Investment Counsel's 13F filing for Q2 2014, filed 12 Aug 2014.